Skip to content
hcg-service-hero-1

Insights From Halloran

Shawn Roach, PhD, RACAug 8, 2024 1:45:00 PM1 min read

Clinical Development Considerations for Small Molecules and Recombinant Proteins

Navigating the complexities of Chemistry, Manufacturing, and Controls (CMC) within the ...
Start Reading
Hema BalasubramanianAug 2, 2024 11:30:00 AM7 min read

How, Why, and When to Apply for an Orphan Drug Application

This article is written by Hema Balasubramanian and Mamta Puri-Lechner. In the rapidly ...
Start Reading
Katie W McCarthyJul 10, 2024 4:33:00 PM1 min read

Key Strategies for Development Stage Biotechs: Developing an Organization and the Talent Within

Watch “Key Strategies for Development Stage Biotechs: Developing an Organization and the ...
Start Reading
Halloran Consulting GroupJul 10, 2024 3:57:00 PM5 min read

Catching Up with Consulting — DIA 2024 Insights

This article is based on opinions and perceptions from the DIA 2024 Global Annual ...
Start Reading
Gail WinslowJul 3, 2024 4:00:00 PM4 min read

Generative AI-Driven Clinical Trials: Are We There Yet?

This article is based on the session titled, “Generative AI-Driven Clinical Trials: Myth ...
Start Reading
Halloran Consulting GroupJul 3, 2024 9:00:00 AM3 min read

Clinical Trials in 2024 - Are We Making the Grade?

Clinical Trials in 2024 - Are We Making the Grade? This article is based on the session ...
Start Reading
Halloran Consulting GroupJul 3, 2024 8:30:00 AM3 min read

The Upside of Artificial Intelligence on Medical Writing

The Upside of Artificial Intelligence on Medical Writing This article is based on the ...
Start Reading
Halloran Consulting GroupJul 2, 2024 9:49:00 AM4 min read

Building Your Leadership Superpowers

Building Your Leadership Superpowers This article is based on the session titled, ...
Start Reading
Gail WinslowJul 2, 2024 8:57:00 AM5 min read

RWD and RWE for Regulatory and Health Technology Assessments

This article is based on the session “Real-World Evidence (RWE) for Regulatory and Health ...
Start Reading
Gail WinslowJul 1, 2024 12:35:00 PM4 min read

Maximizing The Next 40 Years of The Orphan Drug Act 

This article is based on the session titled, “Sustainability of Rare Disease Drug ...
Start Reading